On September 2, 2020 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that Jacob Chacko, M.D., chief executive officer, will participate in the following investor conferences in September (Press release, ORIC Pharmaceuticals, SEP 2, 2020, View Source [SID1234564308]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Virtual Conference – Participating in "Precision Targeted Drugs in Oncology" panel discussion on September 9, 2020, at 11:40 a.m. ET
H.C. Wainwright 22nd Annual Global Investment Conference – Presenting company overview on September 15, 2020, at 10:00 a.m. ET
2020 Cantor Virtual Global Healthcare Conference – Hosting virtual investor meetings on September 17, 2020
Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit – Participating in a virtual fireside chat on September 22, 2020, at 11:40 a.m. ET
Webcasts of the Citi, H.C. Wainwright and Oppenheimer presentations will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the events.